GlaxoSmithKline Pharma to consider Q3 and 9M results

Capital Market

Last Updated : Dec 27 2016 | 11:47 AM IST

On 11 February 2016

GlaxoSmithKline Pharma will hold a board meeting on 11 February 2017 for approval and declaration of Un-Audited Financial Results for the third quarter and nine months ended 31 December 2016.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

Board of Ahluwalia Contracts (India) to consider preferential issue of shares

Godrej Properties provides update on Godrej BKC project in Mumbai

Glenmark Pharmaceuticals gets final approval for Tretinoin Capsules

IAG Company renamed as IAG Glass Company

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Dec 27 2016 | 11:15 AM IST

Explore News

Stock Market LIVE Updates Stocks to Watch Today Trump International Organisation Withdrawal Order IMD Weather Forecast Today Stocks to Buy Today US Denmark Greenland Talks Gold and Silver Price Today UK Dev's Law Stock Market Before Budget 2026 Seeds Bill